Background and Purpose-Stroke imaging is pivotal for diagnosis and stratification of patients with acute ischemic stroke to treatment. The potential of combining multimodal information into reliable estimates of outcome learning calls for robust machine learning techniques with high flexibility and accuracy. We applied the novel extreme gradient boosting algorithm for multimodal magnetic resonance imaging-based infarct prediction. Methods-In a retrospective analysis of 195 patients with acute ischemic stroke, fluid-attenuated inversion recovery, diffusion-weighted imaging, and 10 perfusion parameters were derived from acute magnetic resonance imaging scans. They were integrated to predict final infarct as seen on follow-up T2-fluid-attenuated inversion recovery using the extreme gradient boosting and compared with a standard generalized linear model approach using cross-validation. Submodels for recanalization and persistent occlusion were calculated and were used to identify the important imaging markers. Performance in infarct prediction was analyzed with receiver operating characteristics. Resulting areas under the curve and accuracy rates were compared using Wilcoxon signed-rank test. Results-The extreme gradient boosting model demonstrated significantly higher performance in infarct prediction compared with generalized linear model in both cross-validation approaches: 5-folds (P<10e-16) and leave-one-out (P<0.015). The imaging parameters time-to-peak, mean transit time, time-to-maximum, and diffusion-weighted imaging were indicated as most valuable for infarct prediction by the systematic algorithm rating. Notably, the performance improvement was higher with 5-folds cross-validation approach than leave-one-out. Conclusions-We demonstrate extreme gradient boosting as a state-of-the-art method for clinically applicable multimodal magnetic resonance imaging infarct prediction in acute ischemic stroke. Our findings emphasize the role of perfusion parameters as important biomarkers for infarct prediction. The effect of cross-validation techniques on performance indicates that the intrapatient variability is expressed in nonlinear dynamics of the imaging modalities. (Stroke. 2018;49:912-918.
T he proven efficacy of mechanical intra-arterial recanalization calls for reliable methods to stratify patients into treatment beyond the currently applied time window that restricts treatment of patients with stroke to only several hours from symptoms onset. 1 Acute stroke imaging is a fundamental tool to establish a personalized and reliable approach for diagnosis and stratification of patients with acute ischemic stroke into treatment. 2 Magnetic resonance imaging (MRI), including dynamic susceptibility-enhanced contrast MRI (DSC-MRI), provides a multimodal imaging technique that allows the examination of numerous aspects of the brain tissue through diffusion-weighted imaging (DWI), fluid-attenuated inversion recovery (FLAIR), and perfusion-weighted imaging. 3 In the clinical settings, multimodal imaging aspires to reliably estimate the salvageable tissue to warrant treatment.
To reflect the salvageable tissue by projecting the stroke progression, several attempts have been made to provide an MRIbased model to predict final infarct. [4] [5] [6] Although these publications established the clinical importance of multimodal information for infarct prediction, the debate continues about the best strategies to accomplish this goal. Questions have been raised over the choice of the most suitable MRI modality to identify the salvageable brain tissue, that is, DSC or FLAIR and over the selection of perfusion parameters. [7] [8] [9] [10] [11] Currently in routine clinic, single imaging biomarkers are preferred, but the multifaceted information acquired with MRI likely holds more information to improve the prediction because of the complexity of stroke progression. 3, 10, 12, 13 A straightforward linear combination of markers as was in the generalized linear model (GLM) model of Wu et al 14 may however not be sufficiently to accurately capture the stroke progression complexity. Gradient tree boosting (extreme gradient boosting [XGBoost] ) solves both problems and yet allows assessment of parameter importance. XGBoost was shown to provide state-of-the-art results for various (medical) applications and won numerous awards in the machinelearning field. 15 The algorithm integrates multimodal data for prediction while accounting for complicated and nonlinear dynamics between the different modalities. Moreover, XGBoost facilitates use of all imaging modalities while systematically rating their contribution to the outcome measure. Thus, it allows to identify the important imaging markers for infarct prediction. This approach, therefore, holds great promise for a reliable clinical application to estimate stroke imaging outcome.
In this study, we applied XGBoost for multimodal MRIbased infarct prediction in acute stroke. In 2 submodels, we established infarct prediction for the cases of successful recanalization and persistent occlusion. To assess the performance of the model, we compared it to the standard regression method, that is, GLM. We then derived the contribution of each MRI modality to the predictive model and assessed its importance for infarct prediction.
Material and Methods

Patients
In a retrospective analysis, patients with acute ischemic hemispheric stroke from the I-Know European multicenter study and the Ischemic Perconditioning trial were included. 16, 17 An experienced stroke neurologist supervised the patients during imaging according to stroke unit standards. Patients were triaged with acute MRI into intravenous tissue-type plasminogen activator and conservative therapy. Lacunar stroke syndromes were excluded. The I-Know and Perconditioning studies conformed with the Helsinki declaration, the rules laid out by the Council of Europe Convention on Human rights and Biomedicine, Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995, and with the legislation and regulations in Denmark, Germany, France, and Spain, respectively. The studies were approved by the Aarhus, Hamburg, Lyon, and Girona hospitals and their respective regional ethics committees and performed after informed consent from the patients. Because of the sensitive nature of the data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to Leif Østergaard at leif@cfin.au.dk (I-Know) and Grethe Andersen at grander@rm.dk (Perconditioning). In total 195 patients, of them 117 women, were included. Based on the Thrombolysis In Myocardial Infarction scores evaluation, 81 patients were categorized as successfully recanalized, 36 patients were categorized as persistent occlusion, and 74 patients were not assigned to any of these categories. The median time delay between stroke and MRI was 2.3 hours. Table 1 provides a summary of the clinical characteristics of the included patients.
Imaging
The acute imaging protocol incorporated standard gradient echo DSC-MRI for perfusion-weighted imaging, T2-FLAIR, and DWI. The MRI was conducted at the admitting hospital (GE Signa Excite 1.5T, GE Signa Excite 3T, GE Signa HDx 1.5T, GE Signa Genesis 1.5T, Milwaukee, WI; Siemens-TrioTim 3T, Siemens-Avanto 1.5T, Siemens-Sonata 1.5T, Erlangen, Germany; Philips-Gyroscan NT 1.5T, Phillips-Achieva 3T, and Philips-Intera 1.5T, Best, the Netherlands). The protocols from the 2 studies are described in details elsewhere. 17, 18 Only patients with acute DSC-MRI, DWI, T2-FLAIR scans, and follow-up T2-FLAIR scan were included in this study. The DSC-MRI sequence was obtained during intravenous gadolinium-based contrast injection (0.1 mmol/kg at rate 5 mL/s) followed by 30 mL physiological saline (injected at rate 5 mL/s). Echoplanar DWI was obtained at diffusion weighting of b = 0 s/mm 2 and b = 1000 s/mm 2 . The nonzero images were acquired at 3 to 12 directions, depending on the scanner/vendor type at the admitting hospital.
Data Postprocessing
The postprocessing of the DSC raw images was performed at 1 center and similarly for the 2 cohorts using an in-house software (PGUI, MATLAB). DSC-MRI raw images were processed to generate the following perfusion maps:
-As derived directly from the concentration curve: cerebral blood volume (CBV) labeled as cCBV and time-to-peak (TTP) labeled as TTP. -Using oscillatory singular value decomposition (OSVD) deconvolution: cerebral blood flow labeled as OSVD deconvolution cerebral blood flow, CBV labeled as OSVD deconvolution CBV, mean transit time (MTT) labeled as OSVD deconvolution MTT, and time-to-maximum (Tmax) labeled as OSVD deconvolution Tmax. -Using a statistical (parametric) approach: parametric cerebral blood flow, parametric CBV, parametric MTT, parametric Tmax, relative transit time heterogeneity, capillary transit time heterogeneity, and cerebral metabolic rate of oxygen. The OSVD deconvolution method was selected for its reliability and validity over the standard singular-value decomposition method in stroke imaging. 11, 19 Detailed description of the statistical (parametric) approach is described by Mouridsen et al 2014. 20, 21 Arterial input functions for deconvolution were chosen semiautomatically from the M1 segment of the contralateral hemisphere. Based on variance inflation factor calculation, the parameters cCBV, OSVD deconvolution CBV, and cerebral metabolic rate of oxygen were removed from the analysis to eliminate possible effect of multicollinearities. Therefore in total, 12 imaging parameters were analyzed: DWI, T2-FLAIR, and 10 perfusion parameters. All imaging parameters were normalized to the contralateral white matter (as a difference in time parameters and as a ratio otherwise).
Data Analysis
Final infarct masks were outlined semiautomatically (SGUI, MATLAB) based on follow-up T2-FLAIR images. All images, including follow-up T2-FLAIR, were coregistered per patient to the last volume before bolus arrival of the concentration curve. To deal with class imbalance, the data were subsampled using an in-house tool (VOXAN, MATLAB) to assure equal number of voxels taken from the final infarct region and randomly sampled from the healthy tissue with restriction of minimum 500 voxels taken per patient. This technique is recommended for the training of predictive models. 22 Patients with a final infarct volume <0.12 mL (ie, <5 voxels) were excluded from the analysis (25 patients were excluded on these grounds). 
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Statistical Analysis
The prediction of final infarct in patients with acute ischemic stroke was analyzed as a classification problem. Namely, based on the acute imaging information, each voxel of a patient is classified into 1 of the 2 categories: infarcted or noninfarcted. The XGBoost was used to predict the final infarct on a voxel-based level based on the acute imaging information. To assess the quality of the performance, GLM was chosen for comparison as the standard approach for this voxelbased classification problem.
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XGBoost for Final Infarct Prediction
XGBoost solves the described classification problem by producing a prediction model as an ensemble of weak classification models (ie, classifiers). As an ensemble method, the algorithm builds many weak classifiers in the form of decision trees and then integrates them into 1 cumulative prediction model to obtain better performance than any of the constituent classifiers. Another advantage of the XGBoost is its scalability and portability, namely it can efficiently work on large databases and can be used in different operating environments. 15 For detailed description of the XGBoost algorithm, please see the onlineonly Data Supplement. XGBoost algorithm was applied on the acute magnetic resonance (MR) images, that is, T2-FLAIR, DWI, and 10 different perfusion parameters, to predict final infarct using the xgboost package.
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GLM for Final Infarct Prediction
GLM is a generalization of linear regression that allows to predict a category, that is, a class, instead of a continuous value as standard linear regression. Hence, our model predicts the probability of an infarct (versus noninfarct) based on a set of explanatory variables, that is, acute imaging, according to the following relation:
Where
) is the probability for infarct given the vector X ; Infarct can only take the values 1 for infarct or 0 for no infarct. β stands for the model parameterization.
In the problem at hand, the GLM relates the linear combination of the values of acute MR images to the probability of the voxel to be infarcted. According to the model, the probability is given by:
Where P i is the probability of the voxel i to become infarcted given the acute MR values for this voxel; the parameters T FLAIR DWI cCBV pCMRO
, , , … denote the acute images for voxel i; and β set the model parametrization to be estimated based on the training data.
Integration of Recanalization Status
The predictive models were calculated for 3 cases: (1) The general model that was trained on the full cohort, that is, blinded to the recanalization status. (2) Recanalization model that was trained on successfully recanalized patients. (3) Persistent occlusion model that was trained on nonrecanalized patients. The distribution into 3 models allows estimating the infarct progression with successful recanalization or without it, as well as enabling assessment of the contribution of the recanalization status to the model's performance. Recanalization status was evaluated by a rater blinded to clinical data using the Thrombolysis In Myocardial Infarction scale as assessed on MR angiography images. Recanalization was identified for visible occlusion on acute imaging and Thrombolysis In Myocardial Infarction <2 on 24 hours imaging. Nonrecanalization (persistent occlusion) was identified for visible occlusion on acute imaging and Thrombolysis In Myocardial Infarction >1 on 24 hours imaging. 
Cross-Validation and Estimation of Performance
Cross-validation (CV) is an efficient way for validating a model and for assessing how it will generalize to an independent data set. The applied techniques allow to avoid bias that would otherwise occur if the performance was assessed on the same data that trained the model. The CV was applied in 2 different approaches:
-Leave-one-out (LOO) approach: The model parameterization was determined based on N−1 patients and was then assessed for performance based on the excluded patient. The process was repeated N times, and the final performance was taken as the median of N runs. -Five-folds approach: The model parameters were determined based on 80% of voxels randomly pulled from all patients, and the model performance was then assessed based on the excluded 20% voxels. The process was repeated 100×, and the final performance was taken as the median of 100 runs. The performance was estimated using receiver operating characteristic curve analysis as the area under the curve (AUC) to predict final infarct as depicted by the follow-up T2-FLAIR delineations. In addition, to assess the volumetric error, the error rate of the models was calculated as the percentage of misclassified voxels (based on probability threshold of 0.5). The accuracy is then denoted as 1-error rate.
Comparison of the Models
Both methods were compared according to their performance in predicting final infarct as was indicated by the AUC and accuracy values with the nonparametric Wilcoxon signed-rank test. A standard significance level of P<0.05 was applied.
Derivation of Modalities Importance for Infarct Prediction
The contribution of each MR parameter to the prediction model can be systematically estimated by the XGBoost algorithm. The contribution, also termed as gain, is calculated as the cumulative average of the modality gain over all the constituent decision trees in the ensemble model. The contribution is, therefore, denoted in percent, and the sum of contributions is 100%. High percentage indicates an important modality for prediction of final infarct.
To assess the effect of the vessel recanalization status on the modalities rating, they were calculated separately for 2 groups: (1) successfully recanalized patients and (2) persistent occlusion patients. Patients who did not have visible occlusion in the acute imaging and could not be attributed to 1 of the 2 groups were excluded from this subanalysis.
Results
Performance in Final Infarct Prediction
The XGBoost model demonstrated significantly higher performance in infarct prediction than the GLM for all 3 models and in both CV approaches (P<0.015). Notwithstanding, the difference in performance was highly affected by the CV method. Although the pooled 5-folds CV approach yielded a higher difference in AUC values, the LOO approach resulted in a smaller difference in AUC values. Furthermore, the integration of the recanalization status into the model improved the performance by up to an AUC difference of 0.02. In terms of accuracy, this translates to an improvement of 2% (LOO) to 5% (5-folds) on average in volumetric performance of the infarct assessment (P<10e-5) and reduces the mean misclassified volume per patient from 30 to 26 mL (standard deviation 44 and 38, respectively). For detailed performance values and the statistical test results, see Table 2 . For an illustration of the receiver operating characteristic curve, please see the online-only Data Supplement. An illustration of the final infarct prediction with both models can be found in Figure 1 .
Contribution of MR Features for Final Infarct Prediction
As shown in Figure 2 , for recanalized patients, the most important modality for final infarct prediction was identified by XGBoost as parametric MTT with gain of 40% followed by OSVD deconvolution Tmax (14.5%), DWI (14%), TTP (9%), and parametric Tmax (9%). The rest of the parameters had <5% of contribution to the prediction of final infarct. For nonrecanalized patients, the most important modality was identified as TTP with gain of 46%, followed by parametric MTT (17%), parametric Tmax (12%), OSVD deconvolution Tmax (7%), and DWI (5%). The rest of the parameters had <5% of contribution to the prediction of final infarct.
Discussion
The results of this study demonstrate the XGBoost as a stateof-the-art method for multimodal MRI infarct prediction in acute stroke. We have observed a significant increase in prediction performance using XGBoost algorithm compared with the standard GLM technique. In addition, our findings indicate MTT and TTP as primary parameters for infarct prediction. It is important to emphasize that because our method does not require thresholding or manual input, it can be easily implemented in clinical postprocessing routines to provide the treating physician with an infarct risk map of the treated patient.
Providing imaging-based alternatives to the time window stratification approach plays a crucial role toward an extended and personalized treatment in acute ischemic stroke. This focus is reflected in many reports of multimodal imagingbased predictive models in acute stroke. [3] [4] [5] [6] 26, 27 Our findings support the integrative multimodal approach and introduce XGBoost as a new state-of-the-art algorithm for this purpose. Our results indicate that integration of recanalization status improves the performance of the model. Moreover, the 2 submodels allow to assess the infarct progression in case of successful recanalization and in case of persistent occlusion. Therefore, they provide supplementary information for patient stratification into treatment. The higher P values in the 2 submodels compared with the general model are attributed to the much smaller subdata sets available for patients with recanalization status (81 and 36 recanalized and nonrecanalized patients, respectively, compared with 195 in the full cohort). Translating the effect size into clinically relevant terms, the means of misclassified voxels between the XGB and GLM differed by 2% (LOO) to 5% (5-folds) on average. This rather small difference does not preclude potential clinical value because in boundary cases, the accuracy gain The table compares the performance of the XGBoost (XGB) and the generalized linear model (GLM) in final infarct prediction using receiver operating characteristics (ROC) analysis as measured by the area under the curve (AUC) and the accuracy rate (Acc). The comparison was done using the nonparametric paired Wilcoxon signed-rank test. The performance is presented for the 3 models: (1) The general model, without integration of recanalization status; (2) the model for successful recanalization; and (3) the model for persistent occlusion, for both cross-validation (CV) approaches: leave-one-out (LOO) and 5-folds. The higher P values in the 2 submodels are attributed to the smaller available data sets, comparing with the general model. Figure 1 . Illustration of final infarct prediction for a representative patient. Single parameter perfusion maps of diffusion-weighted imaging (DWI), parametric time-to-maximum (pTmax), time-to-peak (TTP), and parametric mean transit time (pMTT; A) are shown in comparison to a generalized linear model (GLM)-based probability map (GLM) and XGBoost probability map (XGB; B) for final infarct for a representative recanalized patient. As can be observed, the XGBoost-based probability map yields an accurate prediction of final infarct as presented by the T2-fluid-attenuated inversion recovery (FLAIR)-based final infarct layout (B) in comparison with the presented single imaging modalities and the GLM-based probability map (especially in the posterior areas). The illustration reflects the finding that the perfusion parameters pTmax, pMTT, and TTP are viable markers for acute infarction.
could assure correct classification to treatment. The presented model is based on relative parameters that contribute to the strength of the predictive model. Unlike previously suggested models, our approach does not rely on a fixed threshold that is prone to errors because of the impact of preexisting large or small vessel disease on the threshold. The high performance of XGBoost compared with the standard GLM is consistent with many successful recent applications of the algorithm. 15, [27] [28] [29] XGBoost captures complex dynamics of the imaging modalities and is robust to multicollinearity of the input variables. Consequently, it does not only provide an automated integrative framework but also allows for adjustment of prediction based on distinct imaging characteristics, therefore allowing an individual risk assessment for patients with acute ischemic stroke. As an available open-source package, the XBGoost provides a framework for therapy stratification fully applicable to the clinical settings.
According to the systematic analysis of the XGBoost algorithm, the parameters parametric MTT, TTP, DWI, OSVD deconvolution Tmax, and parametric Tmax were rated as most valuable for final infarct prediction in both recanalized and nonrecanalized patients and account for 87% of the gain in both predictive models. According to the penumbra model that distinguishes infarct core and tissue-at-risk, we would expect parameters representing the infarct core to best predict the final infarct in recanalized patients. Respectively, in persistent occlusion, parameters indicative of the tissue-at-risk are expected to best predict the final infarct. Thus, the larger predictive value of DWI in recanalized patients compared with persistent occlusion patients is consistent with the literature, suggesting DWI as an indicative parameter to identify the infarct core. 10, 30 Interestingly, perfusion parameters were found to play an important role in final infarct prediction in recanalized patients. This finding further corroborates previous indications in the literature on the role of perfusion parameters as reliable predictors of disease severity and corresponds with the current interpretation of perfusion parameters in computed tomographic imaging to identify the acute infarct core. 20, 21, 31, 32 The indicated value of MTT as well as Tmax for final infarct prediction in recanalized patients supports the use of deconvolved perfusion parameters in acute stroke imaging. 11, 33 In persistent occlusion patients, however, our results confirm previous studies that showed the importance of nondeconvolved summary parameters, such as TTP for penumbral flow prediction. 8, 9, 13 Thus, our XGBoost results indicate that deconvolved parameters and summary parameters might be beneficial for different types of patients with stroke (recanalized versus nonrecanalized). These results provide guidelines for the development of clinically applicable decision support systems displaying the treating physician canalized and recanalized final infarcts based on different models.
Our study has several limitations. Because of the multicentric origin of our data, it is prone to high variability due to vendor and site differences that can result in a lower performance of the model. Nevertheless, this heterogeneity reflects clinical reality. Because our suggested model is not tailored to a specific protocol and achieved high performance, the presented performance represents its ability for generalization. A note of caution about the parameters ranking is due here owing to 2 reasons: (1) the size of our data set may introduce a certain bias, and (2) the evaluation of the MR modalities contribution to prediction is assessed solely based on the ensemble model properties. Although this calculation is meaningful with relation to the calculated model, the provided results cannot be generalized to infer the performance of each possible nested model. Therefore, the provided rating is not a substitute to a systematic nested model comparison but only offer a recommendation for valid imaging predictors.
One unanticipated finding was the effect of CV choice on the measured performance. Here, it is important to underline an important difference between the 2 CV approaches: in terms of data pooling, 5-folds CV randomly pools voxels from all patients for the training and test sets while LOO separates the data based on individual patients, for example, N−1 patients for the training set and 1 patient for the test set at a time. Although the LOO approach probably better simulates the case of applying the model to a new independent patient, the estimated performance is prone to larger variability comparing to the 5-folds approach because of the smaller test set. Typically, the more the training set resembles the test set, the better the model performance would be. In the 5-folds CV, both training and test set were randomly pooled from all patients, thus making the training and test set more homogeneous. Yet in the LOO CV, the training set and the test set were separated according to the patients, therefore not allowing to generalize interpatient variability. Our results indicate that the XGBoost model demonstrated this second effect prominently. Nevertheless, because the GLM model did not express the same effect, we conclude that the interpatient variability could not be captured by the GLM to the same extent as it was by XGBoost. This interesting finding thus suggests that the interpatient variability is expressed in nonlinear dynamics of the imaging parameters.
Conclusions
The XGBoost algorithm provides an automated, clinically applicable, and precise framework for an integrative multimodal imaging model for final infarct prediction in acute stroke. Our findings highlight the 5 important imaging markers in stroke and indicate a distinction of predictive MRI parameters between recanalized and nonrecanalized patients. Finally, our findings suggest that the interpatient variability is expressed in nonlinear dynamics of the imaging modalities. These results shed new light on predictive modeling in stroke and have important implications for future development of imaging-based stratification tools for patients with acute stroke in the clinical settings.
